Article

Leica, Olympus pair up

Leica Microsystems GmbH now has access to the portfolio of patents held by Olympus America Inc. in the field of digital pathology and virtual microscopy through a nonexclusive worldwide licensing agreement signed by the two companies.

Wetzlar, Germany-Leica Microsystems GmbH now has access to the portfolio of patents held by Olympus America Inc. in the field of digital pathology and virtual microscopy through a nonexclusive worldwide licensing agreement signed by the two companies.

The patents included in the licensing deal cover methods and equipment for creating, storing, and delivering virtual microscopy slides. The technology enables the viewing and sharing of high-resolution virtual microscopy images over the Internet.

“We believe digital slide scanning will be the fastest-growing segment in microscopy for years to come,” said Stefan Traeger, managing director of Leica’s Life Science Division. “This license agreement will enable us to further expand our offering in this space and to provide our customers around the world with a complete solution from digital scanning of microscopy slides to the handling and management of digital pathology data.”

Osamu Joji, group vice president and general manager of Olympus America’s Scientific Equipment Group, said, “We’ve seen interest in digital slide scanning grow rapidly over the past few years. Olympus is the holder of these important patents, and we feel it is vital to allow broad access to these technologies . . . to advance the field of pathology. Ultimately, we hope that implementing these technologies will help enhance health care for patients around the world.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.